(Q54115075)

24 May 2018

review article

1 reference

title

The HER-2/neu oncogene in breast cancer: prognostic factor, predictive factor, and target for therapy. (English)

1 reference

24 May 2018

1 reference

Ross JS

1

1 reference

24 May 2018

Fletcher JA

series ordinal

2

1 reference

24 May 2018

publication date

1 January 1998

1 reference

24 May 2018

published in

Stem Cells

1 reference

24 May 2018

volume

16

1 reference

24 May 2018

page(s)

413-428

1 reference

24 May 2018

issue

6

1 reference

24 May 2018

c-erbB-2 oncoprotein expression in primary and advanced breast cancer

cites work

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

The long term prognostic significance of c-erbB-2 in primary breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

The relationship between c-erbB-2 expression, S-phase fraction and prognosis in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

Prognostic significance of c-erbB-2 expression in node negative breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

c-erbB-2 oncoprotein detected by automated quantitative immunocytochemistry in breast carcinomas correlates with patients' overall and disease-free survival

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

Expression of C-erbB-2 Oncoprotein in Mammary and Extramammary Paget's Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

Relationship between c-erbB-2 protein product expression and response to endocrine therapy in advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

Expression of ras p21, p53 and c-erbB-2 in advanced breast cancer and response to first line hormonal therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

Soluble c-erbB-2 fragment in serum correlates with disease stage and predicts for shortened survival in patients with early-stage and advanced breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

Utility of C-erbB-2 in tissue and in serum in the early diagnosis of recurrence in breast cancer patients: comparison with carcinoembryonic antigen and CA 15.3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

Inhibition of erbB-2-positive breast cancer cell growth by erbB-2 antisense oligonucleotides

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FSTEM.160413

21 January 2018

Identifiers

DOI

10.1002/STEM.160413

1 reference

24 May 2018

PubMed ID

9831867

1 reference

24 May 2018